Kim S, Lee S
Sci Rep. 2025; 15(1):8315.
PMID: 40064931
PMC: 11894134.
DOI: 10.1038/s41598-025-92243-x.
Cassali G, Nakagaki K, Salvi M, Dos Reys M, Rocha M, de Campos C
Vet Sci. 2025; 12(2).
PMID: 40005948
PMC: 11860833.
DOI: 10.3390/vetsci12020189.
Kim S, Yoo D, Park C, Lee S, Lee J, Ahn T
Animals (Basel). 2025; 14(24.
PMID: 39765590
PMC: 11672819.
DOI: 10.3390/ani14243687.
Enginler S, Kucukdeniz T, Dal G, Yildirim F, Cilasun G, Alkan F
Anal Bioanal Chem. 2024; 416(23):5071-5088.
PMID: 39031228
PMC: 11377509.
DOI: 10.1007/s00216-024-05444-0.
Xavier P, Marcao M, Simoes R, Job M, de Francisco Strefezzi R, Fukumasu H
Heliyon. 2024; 10(5):e26714.
PMID: 38439848
PMC: 10909659.
DOI: 10.1016/j.heliyon.2024.e26714.
Prognostic Factors for Cancer-Specific Survival and Disease-Free Interval of Dogs with Mammary Carcinomas.
da Silva Soares E, Valente F, Rocha C, Pereira C, Sarandy T, de Oliveira F
Vet Med Int. 2023; 2023:6890707.
PMID: 37577730
PMC: 10421712.
DOI: 10.1155/2023/6890707.
Canine as a Comparative and Translational Model for Human Mammary Tumor.
Kwon J, Moskwa N, Kang W, Fan T, Lee C
J Breast Cancer. 2023; 26(1):1-13.
PMID: 36762784
PMC: 9981990.
DOI: 10.4048/jbc.2023.26.e4.
Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors.
Brandi A, de Faria Lainetti P, Elias F, Rodrigues M, Fagundes Moraes L, Laufer-Amorim R
Animals (Basel). 2023; 13(1).
PMID: 36611669
PMC: 9817520.
DOI: 10.3390/ani13010060.
COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology.
Vieira T, Oliveira E, Jaime Dos Santos B, Souza F, Veloso E, Nunes C
Front Vet Sci. 2022; 9:983110.
PMID: 36172611
PMC: 9510711.
DOI: 10.3389/fvets.2022.983110.
Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.
Papparella S, Crescio M, Baldassarre V, Brunetti B, Burrai G, Cocumelli C
Vet Sci. 2022; 9(7).
PMID: 35878374
PMC: 9325225.
DOI: 10.3390/vetsci9070357.
MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
Ramadan E, Salem N, Emam I, AbdElkader N, Farghali H, Khattab M
Vet Res Commun. 2021; 46(2):377-388.
PMID: 34787777
DOI: 10.1007/s11259-021-09861-9.
, , , , , , , , and Genes Expression Analysis in Canine Mammary Gland Tumors and the Association with Tumor ClinicoPathological Parameters and Dog Breed Assessment.
Sakalauskaite S, Salteniene V, Nikitina D, Ugenskiene R, Riskeviciene V, Karveliene B
Vet Sci. 2021; 8(10).
PMID: 34679042
PMC: 8537314.
DOI: 10.3390/vetsci8100212.
Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.
Sanchez-Cespedes R, Fernandez-Martinez M, Raya A, Pineda C, Lopez I, Millan Y
BMC Vet Res. 2021; 17(1):197.
PMID: 34034728
PMC: 8152340.
DOI: 10.1186/s12917-021-02901-1.
A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study.
Burrai G, Gabrieli A, Moccia V, Zappulli V, Porcellato I, Brachelente C
Animals (Basel). 2020; 10(9).
PMID: 32961915
PMC: 7552647.
DOI: 10.3390/ani10091687.
One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.
Chocteau F, Mordelet V, Dagher E, Loussouarn D, Abadie J, Nguyen F
Vet Comp Oncol. 2020; 19(1):140-151.
PMID: 32954630
PMC: 7891631.
DOI: 10.1111/vco.12655.
A Preliminary Study of the Cross-Reactivity of Canine MAGE-A with Hominid Monoclonal Antibody 6C1 in Canine Mammary Gland Tumors: An Attractive Target for Cancer Diagnostic, Prognostic and Immunotherapeutic Development in Dogs.
Srisawat W, Nambooppha B, Pringproa K, Thongtharb A, Prachasilchai W, Sthitmatee N
Vet Sci. 2020; 7(3).
PMID: 32784970
PMC: 7558761.
DOI: 10.3390/vetsci7030109.
Mixed tumors of the canine mammary glands: Evaluation of prognostic factors, treatment, and overall survival.
Nunes F, Damasceno K, de Campos C, Bertagnolli A, Lavalle G, Cassali G
Vet Anim Sci. 2020; 7:100039.
PMID: 32734062
PMC: 7386670.
DOI: 10.1016/j.vas.2018.09.003.
Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
Gray M, Meehan J, Martinez-Perez C, Kay C, Turnbull A, Morrison L
Front Oncol. 2020; 10:617.
PMID: 32411603
PMC: 7198768.
DOI: 10.3389/fonc.2020.00617.
Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.
Prado M, Macedo S, Guiraldelli G, de Faria Lainetti P, Leis-Filho A, Kobayashi P
Front Oncol. 2020; 9:1445.
PMID: 31921690
PMC: 6930929.
DOI: 10.3389/fonc.2019.01445.
p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity.
Venanzi F, Gabai V, Mariotti F, Magi G, Vullo C, Sufianov A
Aging (Albany NY). 2019; 11(22):10711-10722.
PMID: 31754084
PMC: 6914433.
DOI: 10.18632/aging.102486.